SNDX

8.7204.49%
SC

Steven Closter

Chief Commercial Officer

Mr. Steven Closter, also known as Steve, is Chief Commercial Officer of Syndax Pharmaceuticals, Inc. from March 18, 2024. Mr. Closter has tricenarian years of commercial experience, which included the oversight of over a dozen product launches and indication expansions. Prior to joining Syndax, he served in various roles at Sunovion Pharmaceuticals, which was consolidated into Sumitomo Pharma America in 2023, ultimately serving as Vice President, Brand Strategy and Launch Excellence. He served in various roles at Sunovion Pharmaceuticals, which was consolidated into Sumitomo Pharma America in 2023, ultimately serving as Vice President, Brand Strategy and Launch Excellence. At Sunovion, he was responsible for global pre-commercialization, launch, marketing, sales and market access strategies for products across neurology, psychiatry and primary care therapeutics. Before Sumitomo, Mr. Closter spent nearly several years in senior marketing and commercial roles at Forest Laboratories, then Allergan, serving as Vice President, Marketing, where he held responsibility for marketing products covering oncology, hospital-based anti-infectives, CNS, cardiovascular and other therapeutic areas. He holds a Bachelor of Science in Business from Cornell University and a Master of Business Administration from the NYU Stern School of Business.

Positions